Trials / Completed
CompletedNCT01929070
A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007
A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007 in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- Male
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the pharmacokinetics of omega-3 between rosuvastatin and omega-3 coadministration and HCP1007 in healthy male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HCP1007 | |
| DRUG | Omarco and Crestor |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2013-08-27
- Last updated
- 2014-03-10
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01929070. Inclusion in this directory is not an endorsement.